Lijuan Ding

444 total citations
24 papers, 227 citations indexed

About

Lijuan Ding is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Lijuan Ding has authored 24 papers receiving a total of 227 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 9 papers in Pulmonary and Respiratory Medicine and 4 papers in Molecular Biology. Recurrent topics in Lijuan Ding's work include Brain Metastases and Treatment (6 papers), CAR-T cell therapy research (4 papers) and Glioma Diagnosis and Treatment (4 papers). Lijuan Ding is often cited by papers focused on Brain Metastases and Treatment (6 papers), CAR-T cell therapy research (4 papers) and Glioma Diagnosis and Treatment (4 papers). Lijuan Ding collaborates with scholars based in China, United States and Austria. Lijuan Ding's co-authors include Bing Sun, He Huang, Xiangying Meng, Yongxian Hu, Jiasheng Wang, Guoqing Wei, Shikai Wu, Zhou Huang, Chao Liu and Santai Song and has published in prestigious journals such as Blood, Scientific Reports and Frontiers in Immunology.

In The Last Decade

Lijuan Ding

21 papers receiving 220 citations

Peers

Lijuan Ding
Jesús Chamorro Spain
Yumiko Higuchi Japan
J.T. Greene United States
Isabella Claudia Glitza United States
Courèche Kaderbhaï France
Marta Escorihuela Spain
Rony Kapoor Australia
Zoë Blake United States
Merel van Gogh Switzerland
Nicholas Coupe United Kingdom
Jesús Chamorro Spain
Lijuan Ding
Citations per year, relative to Lijuan Ding Lijuan Ding (= 1×) peers Jesús Chamorro

Countries citing papers authored by Lijuan Ding

Since Specialization
Citations

This map shows the geographic impact of Lijuan Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lijuan Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lijuan Ding more than expected).

Fields of papers citing papers by Lijuan Ding

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lijuan Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lijuan Ding. The network helps show where Lijuan Ding may publish in the future.

Co-authorship network of co-authors of Lijuan Ding

This figure shows the co-authorship network connecting the top 25 collaborators of Lijuan Ding. A scholar is included among the top collaborators of Lijuan Ding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lijuan Ding. Lijuan Ding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guo, Di, Lijuan Ding, Yang Zhang, et al.. (2025). Dynamic assembly in the rhizosphere microbial community of oilseed rape under uranium stress: On temporal and spatial scales. Applied Soil Ecology. 212. 106206–106206. 1 indexed citations
2.
3.
4.
5.
Zhang, Dandan, et al.. (2025). Association between Pain-Related Quality of Life and Uncontrolled Blood Pressure in Older Hypertensive Patients: Mediating Factors. Annals of Geriatric Medicine and Research. 29(3). 314–325.
6.
Ding, Lijuan, Xin Jiang, Te Li, & Shudong Wang. (2024). Role of UFMylation in tumorigenesis and cancer immunotherapy. Frontiers in Immunology. 15. 1454823–1454823. 4 indexed citations
7.
Wang, Yunyun, et al.. (2023). Mechanism of Valeriana Jatamansi Jones for the treatment of spinal cord injury based on network pharmacology and molecular docking. Medicine. 102(50). e36434–e36434. 5 indexed citations
8.
Ding, Lijuan, Yiyun Wang, Ruimin Hong, et al.. (2021). Efficacy and Safety of Chimeric Antigen Receptor T Cells in Acute Lymphoblastic Leukemia With Post-Transplant Relapse. Frontiers in Oncology. 11. 750218–750218. 9 indexed citations
9.
Wang, Qian, Bing Sun, Chao Liu, et al.. (2019). <p>Brain metastases from breast cancer may respond to endocrine therapy: report of two cases</p>. OncoTargets and Therapy. Volume 12. 1389–1393. 7 indexed citations
10.
Teng, Xinyi, Hao Zhang, Zuyu Liang, et al.. (2019). Galectin-9 from Bone Marrow Mesenchymal Stromal Cells Mediates Immunosuppression on Chimeric Antigen Receptor T Cells. Blood. 134(Supplement_1). 5609–5609. 3 indexed citations
11.
Zheng, Shuai, Salma K. Jabbour, James J. Lu, et al.. (2018). Automated Information Extraction on Treatment and Prognosis for Non–Small Cell Lung Cancer Radiotherapy Patients: Clinical Study. JMIR Medical Informatics. 6(1). e8–e8. 9 indexed citations
12.
Ding, Lijuan, Yongxian Hu, Kui Zhao, et al.. (2018). Pleural cavity cytokine release syndrome in CD19-directed chimeric antigen receptor-modified T cell therapy. Medicine. 97(7). e9992–e9992. 8 indexed citations
13.
Wei, Guoqing, Lijuan Ding, Jiasheng Wang, Yongxian Hu, & He Huang. (2017). Advances of CD19-directed chimeric antigen receptor-modified T cells in refractory/relapsed acute lymphoblastic leukemia. Experimental Hematology and Oncology. 6(1). 10–10. 62 indexed citations
14.
Meng, Xiangying, et al.. (2017). Efficacy and safety of bevacizumab treatment for refractory brain edema. Medicine. 96(44). e8280–e8280. 18 indexed citations
15.
Liu, Chao, Lijuan Ding, Bing Sun, & Shikai Wu. (2016). Bilateral breast adenocarcinomas with EML4&mdash;ALK fusion in a patient with multiple metastases successfully treated with crizotinib: is lung the primary site?. OncoTargets and Therapy. 9. 3589–3589. 2 indexed citations
16.
Liu, Chao, Zhou Huang, Qiusheng Wang, et al.. (2016). Usefulness of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in hormone-receptor-negative breast cancer. OncoTargets and Therapy. Volume 9. 4653–4660. 35 indexed citations
17.
Sun, Bing, Lijuan Ding, Shikai Wu, Santai Song, & Xiangying Meng. (2016). Combined treatment with everolimus and fulvestrant reversed anti-HER2 resistance in a patient with refractory advanced breast cancer: a case report. OncoTargets and Therapy. Volume 9. 3997–4003. 5 indexed citations
18.
Sun, Bing, Zhou Huang, Shikai Wu, et al.. (2015). Incidence and relapse risk of intracranial metastases within the perihippocampal region in 314 patients with breast cancer. Radiotherapy and Oncology. 118(1). 181–186. 29 indexed citations
19.
Zhao, Xin, Xiangying Meng, Bing Sun, et al.. (2013). [Clinical observation of sunitinib treatment for refractory advanced breast cancer ulcer].. PubMed. 93(2). 96–8. 1 indexed citations
20.
Ding, Lijuan, et al.. (2011). A Preliminary Study on Chinese EFL Learners' Attitude towards Their Accent.. ICPhS. 2300–2303. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jesús Chamorro Breakdown of academic impact, for papers by Yumiko Higuchi Breakdown of academic impact, for papers by J.T. Greene Breakdown of academic impact, for papers by Isabella Claudia Glitza Breakdown of academic impact, for papers by Courèche Kaderbhaï Breakdown of academic impact, for papers by Marta Escorihuela Breakdown of academic impact, for papers by Rony Kapoor Breakdown of academic impact, for papers by Zoë Blake Breakdown of academic impact, for papers by Merel van Gogh Breakdown of academic impact, for papers by Nicholas Coupe
Rankless by CCL
2026